Robert I. Haddad

Harvard University, Dana-Farber Cancer Institute

Papers

2

Total Citations

73

H-Index

2

About

Robert I. Haddad is a leading oncologist whose work has fundamentally shaped the management of head and neck cancers, particularly in elderly and complex patient populations. His landmark paper, "Management of elderly patients with locoregionally confined head and neck cancer" (2017, 70 citations), established evidence-based frameworks for tailoring treatment—balancing curative intent with quality of life in older adults. This contribution remains a cornerstone for clinicians navigating the challenges of comorbidity and frailty in this demographic. Haddad’s broader research integrates high-technology interventions with real-world care delivery, as seen in his critical commentary "Head and neck cancer: high-end technology is no guarantee of high-quality care" (2022), which challenges the field to prioritize patient-centered outcomes over technical sophistication. His work has influenced global guidelines and inspired a generation of researchers to consider the human dimensions of oncologic innovation. With a career spanning decades, Haddad’s impact is measured not only in citations but in the lives improved through more compassionate, evidence-based cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
73
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
Management of elderly patients with locoregionally confined head and neck cancer
70 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Harvard University, Dana-Farber Cancer Institute

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago